收稿日期: 2020-04-14
网络出版日期: 2020-09-09
基金资助
国家自然科学基金(81871683)
Effect of PD-1 blockade on immune responses in mice infected with Plasmodium berghei
Received date: 2020-04-14
Online published: 2020-09-09
Supported by
National Natural Science Foundation of China(81871683)
目的 探讨程序性死亡受体-1(PD-1)阻断对小鼠抗伯氏疟原虫ANKA(Plasmodium berghei ANKA,PbA)感染免疫应答的影响。方法 将BALB/c小鼠按照随机数字表法分为健康组、感染组和PD-1组,每组8只。感染组和PD-1组小鼠经腹腔注射1 × 106个PbA感染红细胞,健康组小鼠不作任何处理。感染当天和感染后3、5、7 d,PD-1组每鼠腹腔注射200 μg PD-1单抗,感染组注射等剂量PD-1同型对照单抗。感染后4 d起隔天检测小鼠红细胞感染情况并记录小鼠生存情况。感染后5 d每组各处死4只小鼠,取脾组织,制备脾细胞悬液,流式细胞术检测脾细胞中髓样树突状细胞(mDCs)及PD-1配体(PD-L1)的表达水平、骨髓来源抑制性细胞(MDSCs)和Th1细胞的百分率和绝对数,ELISA检测脾细胞培养上清中细胞因子IFN-γ、IL-10和IL-6分泌水平。结果 感染组小鼠在感染后5~6 d外周血开始出现疟原虫感染红细胞,随后红细胞感染率快速升高,在感染后16 d达到40%左右,PD-1组小鼠红细胞感染率与感染组的相比差异无统计学意义(P > 0.05)。感染组小鼠在感染后15 d出现死亡,23 d全部死亡;PD-1组小鼠在13 d出现死亡,18 d全部死亡,差异有统计学意义(P < 0.05)。流式细胞术检测结果显示,PD-1组脾细胞中CD11c+CD11b+ mDCs百分率为(2.21 ± 0.10)%,明显低于感染组的(4.51 ± 0.21)%(P < 0.05);PD-1组CD4+T-bet+IFN-γ+ Th1百分率为(3.38 ± 0.54)%,低于对照组的(5.85 ± 0.42)%(P < 0.05);mDCs上PD-L1的表达水平,PD-1组为(55.67 ± 6.35)%,高于感染组的(21.35 ± 4.45)%(P < 0.05);Gr-1+CD11b+MDSCs的百分率,PD-1组为(9.03 ± 0.62)%,高于感染组的(3.58 ± 0.16)%(P < 0.05)。脾细胞培养上清中,感染组IFN-γ、IL-6和IL-10的分泌水平分别为(901.69 ± 73.37)、(200.94 ± 4.97)和(551.95 ± 121.71)pg/ml,PD-1组分别为(231.17 ± 57.69)、(86.16 ± 3.93)和(101.72 ± 20.73)pg/ml,PD-1组均低于感染组(P < 0.05)。结论 PD-1阻断可削弱小鼠对PbA感染的保护性免疫应答。
王作玲 , 潘艳艳 , 孙晓丹 , 曹雅明 . PD-1阻断对伯氏疟原虫感染小鼠免疫应答的影响[J]. 中国寄生虫学与寄生虫病杂志, 2020 , 38(4) : 405 -411 . DOI: 10.12140/j.issn.1000-7423.2020.04.001
Objective To investigate the effect of programmed cell death-1(PD-1) blockade on immune responses to the infection of Plasmodium berghei ANKA (PbA) in mice.Methods BALB/c mice were divided by random number table method into 3 groups: the healthy group, infection group and PD-1 group, 8 mice each. Mice in the infection group and PD-1 group were injected intraperitoneally with 1 × 106 PbA-infected red blood cells, while those in the healthy group did not receive any treatment. On the day of infection and on days 3, 5, and 7 after infection, mice in the PD-1 group were injected intraperitoneally with 200 μg of PD-1 monoclonal antibody, while the infection group was injected with equal dose of PD-1 homotype control monoclonal antibody. The erythrocyte infection rate and mice survival rate were monitored every other day from day 4 after infection. On day 5 after infection, 4 mice in each group were sacrificed. Spleen tissues were collected to prepare spleen cell suspensions. Myeloid dendritic cells (mDCs) and the expression of PD-1 ligand (PD-L1) in spleen cells, as well as the percentages and absolute numbers of bone marrow-derived inhibitory cells (myeloid-derived suppressor cells, MDSCs) and Th1 cells were detected by flow cytometry. IFN-γ, IL-6 and IL-10 levels in spleen cell culture supernatant were determined by ELISA.Results In the infection group, Plasmodium-infected red blood cells began to appear in peripheral blood 5-6 days after infection, and then the infection rate of red blood cells increased rapidly, reaching about 40% on day 16 after infection, but there was no difference between the PD-1 group and the infection group. In the infection group, deaths occurred from day 15 after infection and all died by day 23 after infection. In the PD-1 group, deaths occurred from day 13 and all died by day 18. Flow cytometry showed that the percentage of CD11c+CD11b+ mDCs in PD-1 group was (2.21 ± 0.10)%, which was significantly lower than that in the infection group [(4.51 ± 0.21)%, P < 0.05]; the percentage of CD4+T-bet+IFN-γ+ Th1 cells [(3.38 ± 0.54)%] was also lower than that in the infection group [(5.85 ± 0.42)%, P < 0.05]. The expression of PD-L1 on mDCs was higher in PD-1 group [(55.6 ± 6.35)%] than that in the infection group [(21.35 ± 4.45)%, P < 0.05]. The percentage of Gr-1+CD11b+ MDSCs in the PD-1 group [(9.03 ± 0.62)%] was higher than that in the infection group [(3.58 ± 0.16%), P < 0.05]. The levels of IFN-γ, IL-6 and IL-10 in the infection group were (901.69 ± 73.37) pg/ml, (200.94 ± 4.97) pg/ml and (551.95 ± 121.71) pg/ml, respectively, while those in the PD-1 group were (231.17 ± 57.69) pg/ml, (86.1 ± 3.93) pg/ml and (101.72 ± 20.73) pg/ml, respectively.Conclusion PD-1 blockade weakened the protective immune response to PbA infection in mice.
| [1] | Zhang L, Feng J, Xia ZG, et al. Epidemiological characteristics of malaria and progress on its elimination in China in 2019[J]. Chin J Parasitol Parasit Dis, 2020,38(2):133-138. (in Chinese) |
| [1] | ( 张丽, 丰俊, 夏志贵, 等. 2019年全国疟疾疫情特征分析及消除工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2020,38(2):133-138.) |
| [2] | World Health Organization. World Malaria Report 2019 [R]. Geneva: WHO, 2019. |
| [3] | Urban BC, Roberts DJ. Inhibition of T cell function during malaria: implications for immunology and vaccinology[J]. J Exp Med, 2003,197(2):137-141. |
| [4] | Rodrigues V, Cordeiro-da-Silva A, Laforge M, et al. Impairment of T cell function in parasitic infections[J]. PLoS Negl Trop Dis, 2014,8(2):e2567. |
| [5] | Wang J, Shen Y, Li Y, et al. Recent progress in immune checkpoint molecules in Plasmodium infection and immunity[J]. Chin J Parasitol Parasit Dis, 2019,37(4):472-480. (in Chinese) |
| [5] | ( 王军, 沈燕, 李悦, 等. 免疫检查点分子调控在疟原虫感染与免疫中的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2019,37(4):472-480.) |
| [6] | Zheng W, Liu J, Meng DY, et al. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice[J]. Chin J Parasitol Parasit Dis, 2006,24(1):4-18. (in Chinese) |
| [6] | ( 郑伟, 刘军, 孟冬娅, 等. 致死型约氏疟原虫感染DBA/2小鼠保护性免疫机制的研究[J]. 中国寄生虫学与寄生虫病杂志, 2006,24(1):4-18.) |
| [7] | Wykes MN, Horne-Debets JM, Leow CY, et al. Malaria drives T cells to exhaustion[J]. Front Microbiol, 2014,5:249. |
| [8] | Liu TP, Cheng XY, Ding Y, et al. PD-1 deficiency promotes TFH cells expansion in ITV-immunized mice by upregulating cytokines secretion[J]. Parasit Vect, 2018,11(1):397. |
| [9] | Hafalla JC, Claser C, Couper KN, et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology[J]. PLoS Pathog, 2012,8(2):e1002504. |
| [10] | Horne-Debets JM, Faleiro R, Karunarathne DS, et al. PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria[J]. Cell Rep, 2013,5(5):1204-1213. |
| [11] | Kumar R, Loughland JR, Ng SS, et al. The regulation of CD4+T cells during malaria[J]. Immunol Rev, 2020,293(1):70-87. |
| [12] | Dhangadamajhi G, Mohapatra BN, Kar SK, et al. The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection[J]. Parasitol Res, 2009,104(6):1315-1320. |
| [13] | Enyindah-Asonye G, Nwankwo A, Rahman MA, et al. Overexpression of CD6 and PD-1 identifies dysfunctional CD8+ T-cells during chronic SIV infection of rhesus macaques[J]. Front Immunol, 2019,10:3005. |
| [14] | Deguit CDT, Hough M, Hoh R, et al. Some aspects of CD8+ T-cell exhaustion are associated with altered T-cell mitochondrial features and ROS content in HIV infection[J]. J Acquir Immune Defic Syndr, 2019,82(2):211-219. |
| [15] | Zhang C, Rong HM, Li T, et al. PD-1 deficiency promotes macrophage activation and T-helper cell type 1/T-helper cell type 17 response in Pneumocystis pneumonia[J]. Am J Respir Cell Mol Biol, 2020,62(6):767-782. |
| [16] | Fenwick C, Joo V, Jacquier P, et al. T-cell exhaustion in HIV infection[J]. Immunol Rev, 2019,292(1):149-163. |
| [17] | Horne-Debets JM, Faleiro R, Karunarathne DS, et al. PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria[J]. Cell Rep, 2013,5(5):1204-1213. |
| [18] | Zhuang Y, Liu C, Liu J, et al. Resistance mechanism of PD-1/PD-L1 blockade in the cancer-immunity cycle[J]. Onco Targets Ther, 2020,13:83-94. |
| [19] | Brown JA, Dorfman DM, Ma FR, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production[J]. J Immunol, 2003,170(3):1257-1266. |
/
| 〈 |
|
〉 |